id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S17439 R73279 |
Madley-Dowd_SE (Valproate) (Controls exposed to LTG), 2024 | Intellectual disability (intelligence quotient below 70) - ICD-8/9/10 codes - Mean 5-20 years old (according groups° | during pregnancy (anytime or not specified) | population based cohort retrospective | exposed to other treatment, sick excluded | Adjustment: No Partial overlapping |
4.76 [3.06;7.40] C excluded (control group) |
51/792 34/2,383 | 85 | 792 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S17440 R73285 |
Madley-Dowd_SE (Valproate) (Controls unexposed, sick), 2024 | Intellectual disability (intelligence quotient below 70) - ICD-8/9/10 codes - Mean 5-20 years old (according groups) | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed, sick | Adjustment: Yes Partial overlapping | 2.81 [2.05;3.85] | 51/792 194/10,769 | 245 | 792 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S17256 R72220 |
Madley-Dowd_UK (Valproate) (Controls unexposed, sick) (Epilepsy), 2024 | Intellectual disability - ICD10 codes - Median follow up 9.32 (5.54-12.83) years old | during pregnancy (anytime or not specified) | retrospective cohort (claims database) | unexposed, sick | Adjustment: Yes | 1.35 [0.28;6.56] | -/354 13/4,075 | - | 354 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S15877 R65486 |
Dreier (Valproate) (Epilepsy) (Controls exposed to LTG), 2023 | Intellectual disability - Corresponding ICD-10 F-chapter - Up to 22 years of age | during pregnancy (anytime or not specified) | population based cohort propective | exposed to other treatment, sick excluded | Adjustment: No |
6.69 [4.47;10.02] C excluded (control group) |
81/1,952 34/5,288 | 115 | 1,952 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S15878 R65476 |
Dreier (Valproate) (Epilepsy) (Controls unexposed, sick), 2023 | Intellectual disability - Corresponding ICD-10 F-chapter - Up to 22 years of age | during pregnancy (anytime or not specified) | population based cohort propective | unexposed, sick | Adjustment: Yes | 2.70 [1.94;3.74] | 81/1,952 184/22,203 | 265 | 1,952 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S7304 R21154 |
Meador (Valproate), 2013 | IQ <70 (DAS) (at 6 years old) | during pregnancy (anytime or not specified) | prospective cohort | exposed to other treatment, sick | Adjustment: Yes | 7.90 [0.37;168.31] C | 2/49 0/74 | 2 | 49 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S6123 R15992 |
Titze (Valproate) (Controls unexposed, disease free), 2008 | Learning disability (IQ<70) (German versions of the revised Wechsler Intelligence Scales for children and for adults) | during pregnancy (anytime or not specified) | prospective cohort | unexposed, disease free excluded | Adjustment: No Matched |
19.40 [0.31;1195.39] C excluded (control group) |
0/3 0/49 | 0 | 3 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S6124 R15993 |
Titze (Valproate) (Controls unexposed, sick), 2008 | Learning disability (IQ<70) (German versions of the revised Wechsler Intelligence Scales for children and for adults) | during pregnancy (anytime or not specified) | prospective cohort | unexposed, sick | Adjustment: No | 1.53 [0.05;49.80] C | 0/3 1/13 | 1 | 3 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S5543 R14427 |
Viinikainen (Valproate) b, 2006 | Full Scale IQ (FIQ) < 2SD Wechsler Intelligence Scale for Children (WISC III) | throughout pregnancy | prospective cohort | unexposed, sick | Adjustment: No Matched | 5.95 [0.26;138.26] C | 2/13 0/13 | 2 | 13 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S6782 R19153 |
Vinten (Valproate), 2005 | IQ score <69 Wechsler Intelligence Scale for Children (WISC III) (Aged between 6 and 16 years) | during pregnancy (anytime or not specified) | retrospective cohort | unexposed, sick | Adjustment: No | 3.47 [1.14;10.56] C | 9/41 6/80 | 15 | 41 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S7235 R20860 |
Gaily (Valproate) (Controls unexposed, disease free), 2004 | Mental retardation (Verbal and nonverbal IQ <70) | 2nd and/or 3rd trimester | prospective cohort | unexposed, disease free | Adjustment: No | 3.83 [0.37;39.75] C | 1/13 3/141 | 4 | 13 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 8 studies | 2.77 [2.23;3.44] | 534 | 3,217 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: Valproate) (Controls unexposed, sick; 2: Valproate) (Controls unexposed, sick) (Epilepsy; 3: Valproate) (Epilepsy) (Controls unexposed, sick; 4: Valproate; 5: Valproate) (Controls unexposed, sick; 6: Valproate) ; 7: Valproate; 8: Valproate) (Controls unexposed, disease free;
Asymetry test p-value = 0.6476 (by Egger's regression)
slope=0.9900 (0.0852); intercept=0.1302 (0.2707); t=0.4809; p=0.6476
excluded 6123, 15877, 17439